Monday, December 20, 2021 12:57:10 UTC
With an emergency approval for use by the WHO, Novavax is ripping in premarket, and options have been historically adjusting very well for this stock.
The stock increased after World Health Organization granted the vaccine company and the Serum Institute of India an emergency use authorization for their Covid-19 vaccine.
Covovax, which is manufactured and marketed by the Serum Institute for India and other developing nations, has been awarded emergency use status by the WHO.
Novavax's Covid-19 vaccine is protein-based, unlike the vaccines developed by the Pfizer (PFE) and BioNTech (BNTX) alliance and Moderna (MRNA), which are based on messenger RNA drug technology.
NOTE: This is not an endorsement or rejection of vaccines. This is a stock market news item.(More)
RELATED:
N/A []RELATED:
N/A [] Tweets by whale_tips
Wednesday, December 08, 2021 13:03:58 UTC
Pfizer and BioNTech have announced a two-shot vaccine, plus a third booster was able to neutralize the new Omicron variant, and could be ready by March 2022.
Other stocks like American Airlines (AAL) and Carnival Cruises (CCL) rallied in pre-market on the news of potential Omicron defeat success.
Political mayhem continues to surround Covid vaccines, however the news still acutely affects the market.(More)
PFIZER MAY HAVE OMICRON BEAT
Wednesday, December 08, 2021 13:03:58 UTC
Pfizer and BioNTech have announced a two-shot vaccine, plus a third booster was able to neutralize the new Omicron variant, and could be ready by March 2022.
Other stocks like American Airlines (AAL) and Carnival Cruises (CCL) rallied in pre-market on the news of potential Omicron defeat success.
Political mayhem continues to surround Covid vaccines, however the news still acutely affects the market.
#pfizer #biontech #omicron #covid #americanairlines #booster #vaccine
Monday, December 06, 2021 12:58:13 UTC
Cases of the latest Covid variant, omicron have been identified in a third of all U.S. states. The FDA looks to expedite authorization for modified vaccines.
Food and Drug Administration has met with Pfizer, Moderna, and others to rapidly evaluate the safety and efficacy of changes to current vaccinations. Additionally, the FDA is also expected to authorize COVID boosters from Pfizer-BioNTech for use in 16-17 year olds as early as this week.(More)
OMICRON CASES APPROACHING HALF OF USA
Monday, December 06, 2021 12:58:13 UTC
Cases of the latest Covid variant, omicron have been identified in a third of all U.S. states. The FDA looks to expedite authorization for modified vaccines.
Food and Drug Administration has met with Pfizer, Moderna, and others to rapidly evaluate the safety and efficacy of changes to current vaccinations. Additionally, the FDA is also expected to authorize COVID boosters from Pfizer-BioNTech for use in 16-17 year olds as early as this week.
#covid #pfizer #pfe #biontech #bntc #moderna #mrna #vaccine #omicron